Volume 5 Number 2

Website Exclusive Contents!
Exclusive contents: images and/or videos
• Coronary dissection healing patterns: from complete resolution to restenosis. Insights from optical coherence tomography (CTO)
• Early cardiac perforation after percutaneous closure of a patent foramen ovale
Editorial
26
EuroIntervention and EuroPCR 2009. A truly “Grand Cru”
Serruys PW
EuroIntervention 2009;5:167
27
Transcatheter Aortic Valve Implantation. Where are we?
de Jaegere P, Ruiz C, Bonhoeffer P, Vahanian A, Marco J, Serruys PW
EuroIntervention 2009;5:169-171
EAPCI column
28
Notes on clubs and the forming of group identity
Wijns W
EuroIntervention 2009;5:173-175
Focus article
29
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting
García-García H-M, Mintz G, Lerman A, Vince G, Margolis P, van ES G, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys PW
EuroIntervention 2009;5:177-189
Clinical research
30
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)
Routledge H, Lefevre T, Colombo A, Oldroyd K, Hamm C, Guagliumi G, von Scheidt W, Guetta V, Ruzyllo W, Wittebols K, Goedhart D, Serruys PW
31
Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents
Girasis C, Onuma Y, Wong C, Kukreja N, van Domburg R, Serruys PW
EuroIntervention 2009;5:197-205
32
Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience
Parikh K, Shah A, Chag M, Segev A
EuroIntervention 2009;5:206-211
33
Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry
Marso S, Frutkin A, Mehta S, House J, McCrary J, Klauss V, Lerman A, Leon M, Nair A, Margolis P, Erbel R, Nasu K, Schiele F, Margolis J
EuroIntervention 2009;5:212-218
34
Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON)
Rozenman1 Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll H, Spaulding C
EuroIntervention 2009;5:219-223
35
Reproducibility of quantitative optical coherence tomography for stent analysis
Gonzalo N, García-García H-M, Serruys PW, Commissaris K, Bezerra H, Gobbens P, Costa M, Regar E
EuroIntervention 2009;5:224-232
36
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)
Verheye S, Sarno G, Muller R, Birkemeyer R, Vrints C, Jung W, Agostoni P, van Langenhove G, Haine S, Willems T, Haude M, Grube E, Wijns W
EuroIntervention 2009;5:224-232
37
Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention
Lemos P, Campos C, Falcão J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E
EuroIntervention 2009;5:239-243
38
Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions This article contains pictures and/or videos
Noble S, Miro J, Yong G, Bonan R, Tardif J, Ibrahim R
EuroIntervention 2009;5:244-249
39
Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels
Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F
EuroIntervention 2009;5:250-254
40
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.
Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys PW
EuroIntervention 2009;5:255-264
41
Use of the Heartrail II catheter as a distal stent delivery device; an extended case series
Mamas M, Eichhofer E, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D
EuroIntervention 2009;5:265-271
42
Impact of dye injection on intracoronary pressure
Stoel M, Kandhai-Ragunath J, Van Houwelingen G, von Birgelen C
EuroIntervention 2009;5:272-276
Expert review
43
Coronary stenting in warfarin treated patients
Zahger D, Ilia R
EuroIntervention 2009;5:277-281
Volume 5 Number 2 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Medtronic
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X